Clinical studies have shown that TGF-β1, TSP-1 and TGF-Betaiir protein and mRNA expression levels, as well as phosphorylated Smad2/Smad3 levels, are significantly elevated in FSGS cases [42]. Here, SMAD2 is linked to focal segmental glomerulosclerosis.